PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Cetirizine hydrochloride - Allergic rhinitis

PAD Profile : Cetirizine hydrochloride - Allergic rhinitis

Keywords :
Hay fever, hayfever, antihistamines, allergy, seasonal allergic rhinitis, pollen allergy, non-sedating antihistamines
Brand Names Include :
Zirtek, Zirtek allergy, Benadryl allergy liquid release

Traffic Light Status

Status 1 of 3.

Status :
Green
Preferred
Formulations :
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 3.

Status :
Green (see narrative)
Important
Formulations :
  • Oral solution
Important Information :
Loratadine 5mg/5ml sugar free oral solution (from 2 years) is the 1st-line option. Cetirizine liquid is considerably more expensive and is a 2nd line option for patients unable to swallow tablets.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 3 of 3.

Status :
Non Formulary
Formulations :
  • Capsules
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type
Document
Review Date
Guidelines (Local)
01 January 2024

Committee Recommendations

Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

GENERIC Cetirizine has been considered by the APC and has been agreed as a 1st-line treatment option.
Available to purchase.

Liquids reserved for patients unable to swallow solid dose forms.
Loratadine liquid (5mg/5ml) suger free is the 1st-line choice (from 2 years)

Cetirizine liquid (1mg/ml) is 2nd-line option. Safe and effective and can be prescribed from age of 2.


Cetirizine capsules are considerably more costly and are therefore not recommended for routine use within local guidelines

Associated BNF Codes

03. Respiratory System
03.04.01. Antihistamines
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More